LONDON BRIEFING: Phoenix Group hails "impressive" first-half
(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.
Read moreWed, 06th Feb 2019 13:31
(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.
Read more(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.
Read more(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.
Read more(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.
Read more(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.
Read more(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:
Read more(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.
Read more(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.
Read more(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.
Read more(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.
Read more(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.
Read more(Alliance News) - GSK PLC on Wednesday celebrated positive results from the first-ever efficacy trial of its preventative shingles treatment, Shingrix, in China.
Read more(Sharecast News) - GSK reported significant positive findings from its first efficacy trial of the 'Shingrix' shingles vaccine in China on Wednesday.
Read moreCFO David Kemp to retire
*Read moreAug 21 (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.
Read more